SHANGHAI PHARM.HLDG H YC1SHANGHAI PHARM.HLDG H YC1SHANGHAI PHARM.HLDG H YC1

SHANGHAI PHARM.HLDG H YC1

No trades
See on Supercharts
Next report date
Report period
Q2 2024
EPS estimate
0.05EUR
Revenue estimate
‪9.29 B‬EUR
Market capitalization
‪6.81 B‬EUR
‪482.97 M‬EUR
‪33.27 B‬EUR
‪698.44 M‬
Beta (1Y)
0.57

About SHANGHAI PHARMACEUTICALS HOLDING

Headquarters
Shanghai
Employees (FY)
‪48.16 K‬
Founded
1994
ISIN
CNE1000012B3
FIGI
BBG001PPCS90
Shanghai Pharmaceuticals Holding Co., Ltd. engages in the research and development, manufacture, distribution, and retail of pharmaceutical products. The company was founded on January 18, 1994 and is headquartered in Shanghai, China.
Performance
Revenue to profit conversion
Debt level and coverage
Earnings
Next:
‪0.00‬
Summarizing what the indicators are suggesting.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
An aggregate view of professional's ratings.
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Neutral
SellBuy
Strong sellStrong buy
Strong sellSellNeutralBuyStrong buy
Trade directly on the supercharts through our supported, fully-verified and user-reviewed brokers.

Frequently Asked Questions

Depending on the exchange, the stock ticker may vary. For instance, on FWB exchange SHANGHAI PHARM.HLDG H YC1 stocks are traded under the ticker S1R.
SHANGHAI PHARM.HLDG H YC1 is going to release the next earnings report on Aug 29, 2024. Keep track of upcoming events with our Earnings Calendar.
S1R earnings for the last quarter are 0.02 EUR per share, whereas the estimation was 0.07 EUR resulting in a −63.25% surprise. The estimated earnings for the next quarter are 0.05 EUR per share. See more details about SHANGHAI PHARM.HLDG H YC1 earnings.
SHANGHAI PHARM.HLDG H YC1 revenue for the last quarter amounts to ‪8.01 B‬ EUR despite the estimated figure of ‪8.02 B‬ EUR. In the next quarter revenue is expected to reach ‪9.00 B‬ EUR.
Yes, you can track SHANGHAI PHARM.HLDG H YC1 financials in yearly and quarterly reports right on TradingView.
S1R net income for the last quarter is ‪198.66 M‬ EUR, while the quarter before that showed ‪−3.61 M‬ EUR of net income which accounts for ‪5.61 K‬% change. Track more SHANGHAI PHARM.HLDG H YC1 financial stats to get the full picture.
Yes, S1R dividends are paid annually. The last dividend per share was 0.08 EUR. As of today, Dividend Yield (TTM)% is 5.96%. Tracking SHANGHAI PHARM.HLDG H YC1 dividends might help you take more informed decisions.
SHANGHAI PHARM.HLDG H YC1 dividend yield was 3.59% in 2023, and payout ratio reached 36.45%. The year before the numbers were 5.11% and 35.39% correspondingly. See high-dividend stocks and find more opportunities for your portfolio.
Like other stocks, S1R shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade SHANGHAI PHARM.HLDG H YC1 stock right from TradingView charts — choose your broker and connect to your account.
S1R reached its all-time high on May 20, 2015 with the price of 3.18 EUR, and its all-time low was 0.81 EUR and was reached on May 22, 2012. View more price dynamics on S1R chart.
See other stocks reaching their highest and lowest prices.
As of May 2, 2024, the company has ‪48.16 K‬ employees. See our rating of the largest employees — is SHANGHAI PHARM.HLDG H YC1 on this list?
We've gathered analysts' opinions on SHANGHAI PHARM.HLDG H YC1 future price: according to them, S1R price has a max estimate of 2.22 EUR and a min estimate of 1.54 EUR. Watch S1R chart and read a more detailed SHANGHAI PHARM.HLDG H YC1 stock forecast: see what analysts think of SHANGHAI PHARM.HLDG H YC1 and suggest that you do with its stocks.